Enhui Chen

ORCID: 0000-0002-7499-7400
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer-related molecular mechanisms research
  • Liver Disease Diagnosis and Treatment
  • RNA modifications and cancer
  • Lipid metabolism and disorders
  • Peroxisome Proliferator-Activated Receptors
  • Adipokines, Inflammation, and Metabolic Diseases
  • Adipose Tissue and Metabolism
  • Advanced ceramic materials synthesis
  • Hip and Femur Fractures
  • Dialysis and Renal Disease Management
  • Research in Cotton Cultivation
  • Lipid metabolism and biosynthesis
  • Pancreatic function and diabetes
  • Renal cell carcinoma treatment
  • Sperm and Testicular Function
  • Chronic Kidney Disease and Diabetes
  • Multicomponent Synthesis of Heterocycles
  • Intermetallics and Advanced Alloy Properties
  • Renal Diseases and Glomerulopathies
  • Polyamine Metabolism and Applications
  • Fiber-reinforced polymer composites
  • Receptor Mechanisms and Signaling
  • Hormonal and reproductive studies
  • Ubiquitin and proteasome pathways
  • Composite Material Mechanics

Hangzhou Hospital of Traditional Chinese Medicine
2025

Zhejiang Chinese Medical University
2025

Chinese Academy of Medical Sciences & Peking Union Medical College
2022-2024

Xingtai People's Hospital
2024

University of Chinese Academy of Sciences
2024

Tianjin Institute of Industrial Biotechnology
2024

Chinese Academy of Sciences
2024

Hebei Medical University
2024

Wuhan University
2021

Ministry of Education of the People's Republic of China
2015

Background In diabetic patients, non-diabetic kidney disease (NDKD) may occur independently or alongside (DKD). This study explored the utility of biopsy in type 2 diabetes mellitus (T2DM) patients and predictability diagnosing DKD combined with NDKD using clinical laboratory data. Methods retrospective examines medical records T2DM who underwent percutaneous renal at Hangzhou TCM Hospital, Zhejiang Chinese Medical University, from 2012 to 2023. The patient’s demographic, clinical, blood...

10.3389/fendo.2025.1493521 article EN cc-by Frontiers in Endocrinology 2025-03-07

Abstract Background Metastasis renal cell carcinoma (RCC) patients have extremely high mortality rate. A predictive model for RCC micrometastasis based on pathomics could be beneficial clinicians to make treatment decisions. Methods total of 895 formalin-fixed and paraffin-embedded whole slide images (WSIs) derived from three cohorts, including Shanghai General Hospital (SGH), Clinical Proteomic Tumor Analysis Consortium (CPTAC) Cancer Genome Atlas (TCGA) another 588 frozen section WSIs TCGA...

10.1186/s12967-024-05382-6 article EN cc-by Journal of Translational Medicine 2024-06-14

Utilizing<italic>N</italic>,<italic>N</italic>′-bis(carboxymethyl)-<sc>L</sc>-lysine (ANTA) combined with bivalent metal cation Ni<sup>2+</sup>, which leaving free sites for the reversible binding of gene recombinant histidine-tagged β<sub>2</sub>-adrenoceptor onto silica gel.

10.1039/c5ra01012h article EN RSC Advances 2015-01-01

Healthy adipose tissue is crucial to maintain normal energy homeostasis. Little known about the role of murine double minute 2 (MDM2), an E3 ubiquitin ligase and has been highlighted in oncopathology, tissue. Our results indicated that MDM2 expression was associated with nutritional status. Mdm2 adipocyte-specific knock-in (Mdm2-AKI) mice exhibited exacerbated weight gain, insulin resistance, decreased expenditure. Meanwhile, chronic high-fat diet (HFD) exposure caused obvious epididymal...

10.1016/j.isci.2022.104544 article EN cc-by iScience 2022-06-07

LncRNAs are involved in modulating the individual risk and severity of progression metabolic dysfunction-associated fatty liver disease (MASLD), but their precise roles remain largely unknown. This study aimed to investigate role lncRNA Snhg3 development MASLD, along with underlying mechanisms. The result showed that was significantly downregulated high-fat diet-induced obesity (DIO) mice. Notably, palmitic acid promoted expression overexpression increased lipid accumulation primary...

10.7554/elife.96988.4 article EN cc-by eLife 2024-10-22

LncRNAs are involved in modulating the individual risk and severity of progression metabolic dysfunction-associated fatty liver disease (MASLD), but their precise roles remain largely unknown. This study aimed to investigate role lncRNA Snhg3 development MASLD, along with underlying mechanisms. The result showed that was significantly downregulated high-fat diet-induced obesity (DIO) mice. Notably, palmitic acid promoted expression overexpression increased lipid accumulation primary...

10.7554/elife.96988 article EN cc-by eLife 2024-05-13

LncRNAs are involved in modulating the individual risk and severity of progression metabolic dysfunction-associated fatty liver disease (MASLD), but their precise roles remain largely unknown. This study aimed to investigate role lncRNA Snhg3 development MASLD, along with underlying mechanisms. In vitro vivo experiments revealed that is lipid metabolism steatosis. The result showed was significantly downregulated high-fat diet-induced obesity (DIO) mice. Notably, palmitic acid promoted...

10.7554/elife.96988.2 preprint EN 2024-08-22

LncRNAs are involved in modulating the individual risk and severity of progression metabolic dysfunction-associated fatty liver disease (MASLD), but their precise roles remain largely unknown. This study aimed to investigate role lncRNA Snhg3 development MASLD, along with underlying mechanisms. In vitro vivo experiments revealed that is lipid metabolism steatosis. The result showed was significantly downregulated high-fat diet-induced obesity (DIO) mice. Notably, palmitic acid promoted...

10.7554/elife.96988.3 preprint EN 2024-09-16

Abstract LncRNAs are involved in modulating the individual risk and severity of progression metabolic dysfunction-associated fatty liver disease (MASLD), but their precise roles remain largely unknown. This study aimed to investigate role lncRNA Snhg3 development MASLD, along with underlying mechanisms. The result showed that was significantly downregulated high-fat diet-induced obesity (DIO) mice. Notably, palmitic acid promoted expression overexpression increased lipid accumulation primary...

10.1101/2024.03.22.586335 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-03-23

LncRNAs are involved in modulating the individual risk and severity of progression metabolic dysfunction-associated fatty liver disease (MASLD), but their precise roles remain largely unknown. This study aimed to investigate role lncRNA Snhg3 development MASLD, along with underlying mechanisms. In vitro vivo experiments revealed that is lipid metabolism steatosis. The result showed was significantly downregulated high-fat-induced obesity (DIO) mice. Notably, palmitic acid promoted expression...

10.7554/elife.96988.1 preprint EN 2024-05-13

Long noncoding RNAs (lncRNAs) are strongly associated with glucose homeostasis, but their roles remain largely unknown. In this study, the potential role of lncRNA-Snhg3 in metabolism was evaluated both vitro and vivo. Here, we found a positive relationship between Snhg3 hepatic glycogenesis. Glucose tolerance improved hepatocyte-specific knock-in (Snhg3-HKI) mice, while it worsened knockout (Snhg3-HKO) mice. Furthermore, glycogenesis had shown remarkable increase Snhg3-HKI mice reduction...

10.1096/fj.202401064r article EN The FASEB Journal 2024-08-12

10.1016/s1071-5576(97)86292-2 article EN Journal of the Society for Gynecologic Investigation 1998-01-01

10.1016/s1071-5576(97)86291-0 article EN Journal of the Society for Gynecologic Investigation 1998-01-01
Coming Soon ...